Natural Products
| Catalog No. | Information |
| CFN95241 | Polygalacin D2 Polygalacin D2 may have antimicrobial activity. |
| CFN95240 | Platycogenin A Reference standards. |
| CFN95239 | Gypenoside XIII Reference standards. |
| CFN95238 | 3-Acetyl-ginsenoside F1 Reference standards. |
| CFN70479 | Apioline Reference standards. |
| CFN70466 | Manassantin B Manassantin B is a potent inhibitor of NF-κB activation by the suppression of transciptional activity of RelA/p65 subunit of NF-κB. It also possesses anti-EBV lytic replication activity. Manassantin B inhibits interleukin-6-induced signal transducer and activator of transcription 3 activation in Hep3B cells, it has potential as a potent anti-inflammatory drug for use in pathological processes such as sepsis or acute lung injury. Manassantin B exerts antifibrotic activity in HSC-T6 cells, in part, via inhibition of cell proliferation and decrease of collagen production. |
| CFN70401 | 2',4'-Dihydroxydihydrochalcone 2',4'-Dihydroxydihydrochalcone has cytotoxic, and anti-inflammatory activities. |
| CFN70398 | Picein Total phenolic glycosides, fragilin, Picein, salicortin, tremulacin, and tremuloidin all correlated positively with shoot length in glasshouse plants on a carbon-biased balance, and male willows had generally lower levels of phenolic glycosides than females. |
| CFN70356 | Cupressuflavone Cupressuflavone has hepatoprotective, analgesic and anti‐inflammatory effects. Cupressuflavone could exert a beneficial effect against oxidative stress by enhancing the antioxidant defense status, reducing lipid peroxidation, and protecting against the pathological changes induced by CCl4 in the liver and kidney tissues. |
| CFN70348 | Caffeoyl alcohol Reference standards. |
| CFN70335 | Quercetin 3-rutinoside 7-glucoside (Morkotin A) Reference standards. |
| CFN70333 | Quercetin 3,4'-diglucoside Quercetin 3,4'-diglucoside possesses antioxidant activities. |
| CFN70318 | Peltatoside Peltatoside has antinociceptive and antioxidative effects, it is capable of inducing analgesia through the activation of peripheral CB1 receptors, involving endocannabinoids in this process. |
| CFN70314 | Cimicifugic acid F Cimicifugic acid F has antioxidant activity. Cimicifugic acid F shows inhibition of neutrophil elastase activity with an IC50 of 18 mumol/L. It also shows strong hyaluronidase inhibitory activity. |
| CFN70309 | 11-Oxomogroside IIIE Reference standards. |
| CFN70305 | Fortunellin Fortunellin is a potential anti-inflammation agent in inflammatory diseases, it targets miR-374a, which is a negative regulator of phosphatase and tensin homolog (PTEN). Fortunellin protects against high fructose-induced diabetic heart injury in mice by suppressing inflammation and oxidative stress via AMPK/Nrf-2 pathway regulation. |
| CFN70259 | Rebaudioside M Rebaudioside M is a natural sweetener. |
| CFN95237 | Tigloylgomisin O Reference standards. |
| CFN95236 | Methylgomisin O Methylgomisin O has anti- inflammatory activity, it -induced attenuation of inflammatory cytokine production upon exposure to LPS was at least partially mediated by the suppression of NF-κB and MAPK pathway. Methylgomisin O exhibits strong cytotoxic effects on HL-60. It exhibits considerable inhibitory activity against tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6). |
| CFN95235 | Trachelogenin 4'-O-beta-gentiobioside Reference standards. |
| CFN95234 | Nortrachelogenin-8'-O-beta-glucoside Reference standards. |
| CFN95233 | Geoside Reference standards. |
| CFN95232 | Ginsenoside MC Ginsenoside MC exhibits potent antitumor activity. Ginsenoside MC has improving anti-aging, anti-acne, anti-inflammatory, anti-microbial and moisturizing effects and promoting hair growth and anti-dandruff effect. |
| CFN95231 | Ginsenoside Rd2 (Quinquenoside L10) Reference standards. |
| CFN95230 | Stevioside D Reference standards. |
| CFN95229 | Stevia impurity (13-[(2-O-6-deoxy-beta-D-glucopyranosyl-3-O-beta-D-glucopyranosyl-beta-D-glucopyranosyl)oxy]ent-kaur-16-en-19-oic acid beta-D-glucopyranosyl ester) Reference standards. |
| CFN95228 | 3-O-methylellagic acid 4'-O-alpha-L-rhamnopyranoside Reference standards. |
| CFN95227 | (3R,5S,E)-1,7-Diphenylhept-1-ene-3,5-diol Reference standards. |
| CFN95226 | Pieceid-2''-O-gallate Pieceid-2''-O-gallate has antioxidant activity. |
| CFN95225 | Isolappaol C Reference standards. |
| CFN95224 | Isolappaol A Isolappaol A can up-regulate the expression of jnk-1, it may promote the Caenorhabditis elegans longevity and stress resistance through a JNK-1-DAF-16 cascade. |
| CFN91865 | Cyanidin-3-O-sambubioside-5-O-glucoside chloride |
| CFN91870 | Delphinidin-3-O-sambubioside-5-O-glucoside chloride Delphinidin-3-O-sambubioside-5-O-glucoside chloride suppresses the light-induced photoreceptor cell death by inhibiting ROS production, suggesting that the inhibition of phosphorylated-p38 may be involved in the underlying mechanism. |
| CFN95223 | Schisphenin E Reference standards. |
| CFN95222 | Isovalerylshikonin Isovalerylshikonin, a new resistance-modifying agent from Arnebia euchroma, supresses antimicrobial resistance of drug-resistant Staphylococcus aureus; it also has anti-mite activity. Isovalerylshikonin as a candidate of AChE inhibitor, it may prevent apoptotic cell death induced by hydrogen peroxide in human and rat neuronal SH-SY5Y and PC12 cells. |
| CFN95221 | Arisanschinin E Reference standards. |
| CFN95220 | 2-Methoxyfuranoguaia-9-ene-8-one Reference standards. |
| CFN95219 | (1E)-3-methoxy-8,12-epoxygermacra-1,7,10,11-tetraen-6-one Reference standards. |
| CFN95218 | Notoptol Reference standards. |
| CFN91171 | Procyanidin B4 Procyanidin B4 reveals significant antioxidant activity. |
| CFN95217 | 19-O-beta-D-carboxyglucopyranosyl-12-O-beta-D-glucopyranosyl-11,16-dihydroxyabieta-8,11,13-triene Reference standards. |
| CFN95216 | Bruceantinol B Reference standards. |
| CFN95215 | Rebaudioside F Reference standards. |
| CFN95214 | 1,2-Epoxy-10(14)-furanogermacren-6-one Reference standards. |
| CFN95213 | Licoflavanone Licoflavanone exhibits antioxidant and anti-inflammatory activities,it markedly decreases pro-inflammatory cytokines and cyclooxygenase 2/inducible nitric oxide synthase (COX-2/iNOS) expression levels. |
| CFN95212 | Epischisandrone Reference standards. |
| CFN95211 | Arisantetralone B Reference standards. |
| CFN95210 | Andrographidine A Reference standards. |
| CFN95209 | 5-Hydroxy-7,8-dimethoxy (2R)-flavanone-5-O-beta-D-glucopyranoside Reference standards. |
| CFN95208 | Quercetin 7-O-(6''-O-malonyl)-beta-D-glucoside Reference standards. |
